Skip to main content
. 2002 Dec;68(12):5956–5964. doi: 10.1128/AEM.68.12.5956-5964.2002

TABLE 1.

Strains and plasmids used in this study

Strain or plasmid Descriptiona Source or reference
E. coli
    DH5α F, φ80 lacZΔM15 endA1 recA1 hsdR17(rK mK+) supE44 thi-1 ΔgyrA96 (ΔlacZYA-argF)U169 relA1 Lab stocks
Burkholderia sp.
    ATCC 25416 B. cepacia, genomovar I, environmental isolate D. P. Speert
    CEP509 B. cepacia, genomovar I, clinical isolate D. P. Speert
    Cep484 B. multivorans, clinical isolate D. P. Speert
    C5424 B. cepacia, genomovar III, clinical isolate D. P. Speert
    C4455 B. cepacia, genomovar III, clinical isolate D. P. Speert
    K56-2 B. cepacia, genomovar III, clinical isolate D. P. Speert
    CEP559 B. stabilis, clinical isolate D. P. Speert
    CEP040 B. vietnamiensis, clinical isolate D. P. Speert
    CEP021 B. cepacia, genomovar VI, clinical isolate D. P. Speert
    LB400 Burkholderia sp., environmental isolate S. Sehay
Plasmids
    pME6000 pBBR1 ori, TetrlacZ mob+ S. Heeb
    pML50 pME6000, PS7-dhfr This study
    pML51 pME6000, promoterless dhfr This study
    pML52 pME6000, araC-PBAD-dhfr This study
    pBAD24 AraC AmprcolE1 D.E. Heinrichs
    pRK2013 RK2 derivative, Kmrmob+tra+ ColE1 15
    pTnMod-OTp′ Plasposon, Tpr 13
    pMLS7 pBBR1 ori, PS7 promoter, Tprmob+ This study
    pMLBAD pBBR1 ori, araC-PBAD Tprmob+ This study
    pMLS7-eGFP pMLS7, e-gfp This study
    pMLBAD-eGFP pMLBAD, e-gfp This study
    pML53 pMLBAD-eGFP, PDHFR-araE This study
    pIJ8668 e-gfp Aprr 40
a

Ampr, ampicillin resistance; Aprr, apramycin resistance; Kmr, kanamycin resistance; Tetr, tetracycline resistance; Tpr, trimethoprim resistance.